PDB91 - EXPLAINING THE DISPARITIES OF MARKET ACCESS FOR GLIFLOZINS IN FRANCE, SPAIN, GERMANY AND THE UNITED-KINGDOM
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.796
https://www.valueinhealthjournal.com/article/S1098-3015(18)34096-8/fulltext
Title :
PDB91 - EXPLAINING THE DISPARITIES OF MARKET ACCESS FOR GLIFLOZINS IN FRANCE, SPAIN, GERMANY AND THE UNITED-KINGDOM
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)34096-8&doi=10.1016/j.jval.2018.09.796
First page :
Section Title :
Open access? :
No
Section Order :
199